130 related articles for article (PubMed ID: 26068529)
1. Accurate identification of UDP-glucuronosyltransferase 1A1 (UGT1A1) inhibitors using UGT1A1-overexpressing HeLa cells.
Sun H; Zhou X; Wu B
Xenobiotica; 2015; 45(11):945-53. PubMed ID: 26068529
[TBL] [Abstract][Full Text] [Related]
2. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of in vitro inhibitors against UDP-glucuronosyltransferase 1A1 in uva-ursi extracts and evaluation of in vivo uva-ursi-drug interactions.
Park JB; Kim D; Min JS; Jeong S; Cho DY; Zheng YF; Yoon KD; Bae SK
Food Chem Toxicol; 2018 Oct; 120():651-661. PubMed ID: 30075316
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia.
Miners JO; Chau N; Rowland A; Burns K; McKinnon RA; Mackenzie PI; Tucker GT; Knights KM; Kichenadasse G
Biochem Pharmacol; 2017 Apr; 129():85-95. PubMed ID: 28065859
[TBL] [Abstract][Full Text] [Related]
5. Acyl glucuronidation of fluoroquinolone antibiotics by the UDP-glucuronosyltransferase 1A subfamily in human liver microsomes.
Tachibana M; Tanaka M; Masubuchi Y; Horie T
Drug Metab Dispos; 2005 Jun; 33(6):803-11. PubMed ID: 15769885
[TBL] [Abstract][Full Text] [Related]
6. Characterization of niflumic acid as a selective inhibitor of human liver microsomal UDP-glucuronosyltransferase 1A9: application to the reaction phenotyping of acetaminophen glucuronidation.
Miners JO; Bowalgaha K; Elliot DJ; Baranczewski P; Knights KM
Drug Metab Dispos; 2011 Apr; 39(4):644-52. PubMed ID: 21245288
[TBL] [Abstract][Full Text] [Related]
7. In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation.
Zhang D; Chando TJ; Everett DW; Patten CJ; Dehal SS; Humphreys WG
Drug Metab Dispos; 2005 Nov; 33(11):1729-39. PubMed ID: 16118329
[TBL] [Abstract][Full Text] [Related]
8. UDP-glucuronosyltransferase 1A1 is the principal enzyme responsible for etoposide glucuronidation in human liver and intestinal microsomes: structural characterization of phenolic and alcoholic glucuronides of etoposide and estimation of enzyme kinetics.
Wen Z; Tallman MN; Ali SY; Smith PC
Drug Metab Dispos; 2007 Mar; 35(3):371-80. PubMed ID: 17151191
[TBL] [Abstract][Full Text] [Related]
9. Glucuronidation of antiallergic drug, Tranilast: identification of human UDP-glucuronosyltransferase isoforms and effect of its phase I metabolite.
Katoh M; Matsui T; Yokoi T
Drug Metab Dispos; 2007 Apr; 35(4):583-9. PubMed ID: 17220234
[TBL] [Abstract][Full Text] [Related]
10. In vitro inhibitory effects of non-steroidal antiinflammatory drugs on UDP-glucuronosyltransferase 1A1-catalysed estradiol 3beta-glucuronidation in human liver microsomes.
Mano Y; Usui T; Kamimura H
Biopharm Drug Dispos; 2005 Jan; 26(1):35-9. PubMed ID: 15593333
[TBL] [Abstract][Full Text] [Related]
11. Substrate-dependent modulation of UDP-glucuronosyltransferase 1A1 (UGT1A1) by propofol in recombinant human UGT1A1 and human liver microsomes.
Mano Y; Usui T; Kamimura H
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):211-4. PubMed ID: 17697043
[TBL] [Abstract][Full Text] [Related]
12. Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A1 enzymes.
Hanioka N; Tanabe N; Jinno H; Tanaka-Kagawa T; Nagaoka K; Naito S; Koeda A; Narimatsu S
Life Sci; 2010 Aug; 87(7-8):261-8. PubMed ID: 20620155
[TBL] [Abstract][Full Text] [Related]
13. Pazopanib interacts with irinotecan by inhibiting UGT1A1-mediated glucuronidation, but not OATP1B1-mediated hepatic uptake, of an active metabolite SN-38.
Iwase M; Fujita KI; Nishimura Y; Seba N; Masuo Y; Ishida H; Kato Y; Kiuchi Y
Cancer Chemother Pharmacol; 2019 May; 83(5):993-998. PubMed ID: 30810774
[TBL] [Abstract][Full Text] [Related]
14. In vitro UGT1A1 inhibition by tyrosine kinase inhibitors and association with drug-induced hyperbilirubinemia.
Qosa H; Avaritt BR; Hartman NR; Volpe DA
Cancer Chemother Pharmacol; 2018 Nov; 82(5):795-802. PubMed ID: 30105461
[TBL] [Abstract][Full Text] [Related]
15. Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humans.
Kato Y; Ikushiro S; Emi Y; Tamaki S; Suzuki H; Sakaki T; Yamada S; Degawa M
Drug Metab Dispos; 2008 Jan; 36(1):51-5. PubMed ID: 17908920
[TBL] [Abstract][Full Text] [Related]
16. Absolute quantification of UGT1A1 in various tissues and cell lines using isotope label-free UPLC-MS/MS method determines its turnover number and correlates with its glucuronidation activities.
Xu B; Gao S; Wu B; Yin T; Hu M
J Pharm Biomed Anal; 2014 Jan; 88():180-90. PubMed ID: 24055854
[TBL] [Abstract][Full Text] [Related]
17. Glucuronidation of capsaicin by liver microsomes and expressed UGT enzymes: reaction kinetics, contribution of individual enzymes and marked species differences.
Sun H; Wang H; Liu H; Zhang X; Wu B
Expert Opin Drug Metab Toxicol; 2014 Oct; 10(10):1325-36. PubMed ID: 25219630
[TBL] [Abstract][Full Text] [Related]
18. Correlation between bilirubin glucuronidation and estradiol-3-gluronidation in the presence of model UDP-glucuronosyltransferase 1A1 substrates/inhibitors.
Zhou J; Tracy TS; Remmel RP
Drug Metab Dispos; 2011 Feb; 39(2):322-9. PubMed ID: 21030469
[TBL] [Abstract][Full Text] [Related]
19. Glucuronidation of edaravone by human liver and kidney microsomes: biphasic kinetics and identification of UGT1A9 as the major UDP-glucuronosyltransferase isoform.
Ma L; Sun J; Peng Y; Zhang R; Shao F; Hu X; Zhu J; Wang X; Cheng X; Zhu Y; Wan P; Feng D; Wu H; Wang G
Drug Metab Dispos; 2012 Apr; 40(4):734-41. PubMed ID: 22238289
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Human UDP-Glucuronosyltransferase Enzymes by Canagliflozin and Dapagliflozin: Implications for Drug-Drug Interactions.
Pattanawongsa A; Chau N; Rowland A; Miners JO
Drug Metab Dispos; 2015 Oct; 43(10):1468-76. PubMed ID: 26180128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
